Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study
Thiago Cerqueira‐Silva, Jason R. Andrews, Viviane Boaventura, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 6, pp. 791-801
Open Access | Times Cited: 120

Showing 1-25 of 120 citing articles:

Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022
Nana Wu, Keven Joyal‐Desmarais, Paula Aver Bretanha Ribeiro, et al.
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 5, pp. 439-452
Open Access | Times Cited: 187
Effectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis
Wing Ying Au, Peter Pak‐Hang Cheung
BMJ (2022), pp. e069989-e069989
Open Access | Times Cited: 126
T Cell Responses to SARS-CoV-2
Alessandro Sette, John Sidney, Shane Crotty
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 343-373
Closed Access | Times Cited: 114
Effectiveness of COVID-19 mRNA Vaccination in Preventing COVID-19–Associated Hospitalization Among Adults with Previous SARS-CoV-2 Infection — United States, June 2021–February 2022
Ian D. Plumb, Leora R. Feldstein, Eric Barkley, et al.
MMWR Morbidity and Mortality Weekly Report (2022) Vol. 71, Iss. 15, pp. 549-555
Open Access | Times Cited: 92
A Systematic Review of Coronavirus Disease 2019 Vaccine Efficacy and Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Disease
Melissa M. Higdon, Brian Wahl, Carli B. Jones, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 6
Open Access | Times Cited: 82
Mucosal immunity: The missing link in comprehending SARS-CoV-2 infection and transmission
Michael W. Russell, Jiří Městecký
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 77
Globally approved vaccines for COVID-19: a systematic review
Bárbara Magalhães, Jéssica Medeiros Minasi, Rubens Cáurio Lobato, et al.
Brazilian Journal of Microbiology (2025)
Closed Access | Times Cited: 1
Vaccine effectiveness of CoronaVac against COVID-19 among children in Brazil during the Omicron period
Pilar Tavares Veras Florentino, Flávia Jôse Oliveira Alves, Thiago Cerqueira‐Silva, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 47
Understanding “Hybrid Immunity”: Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Vaccines
Nusrat J Epsi, Stephanie A Richard, David A Lindholm, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e439-e449
Open Access | Times Cited: 46
Vaccination plus previous infection: protection during the omicron wave in Brazil
Thiago Cerqueira‐Silva, Vinícius de Araújo Oliveira, Enny S. Paixão, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 7, pp. 945-946
Open Access | Times Cited: 44
Effectiveness of BNT162b2 and CoronaVac vaccinations against mortality and severe complications after SARS-CoV-2 Omicron BA.2 infection: a case–control study
Vincent Ka Chun Yan, Eric Yuk Fai Wan, Xuxiao Ye, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2304-2314
Open Access | Times Cited: 44
Development of therapeutic vaccines for the treatment of diseases
Yaomei Tian, Die Hu, Yuhua Li, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 44
Expert review on global real-world vaccine effectiveness against SARS-CoV-2
Sunate Chuenkitmongkol, Rontgene Solante, Erlina Burhan, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 9, pp. 1255-1268
Open Access | Times Cited: 38
Prior SARS-CoV-2 infection enhances and reshapes spike protein–specific memory induced by vaccination
Véronique Barateau, Loïc Peyrot, Carla Saade, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 687
Open Access | Times Cited: 23
SARS-CoV-2: Immunity, Challenges with Current Vaccines, and a Novel Perspective on Mucosal Vaccines
Raju Sunagar, Amit Kumar Singh, Sudeep Kumar
Vaccines (2023) Vol. 11, Iss. 4, pp. 849-849
Open Access | Times Cited: 23
Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK
Jia Wei, Philippa C. Matthews, Nicole Stoesser, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Hybrid immunity expands the functional humoral footprint of both mRNA and vector-based SARS-CoV-2 vaccines
Paulina Kapłonek, Yixiang Deng, Jessica Shih-Lu Lee, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 5, pp. 101048-101048
Open Access | Times Cited: 21
What makes SARS‐CoV‐2 unique? Focusing on the spike protein
Jingbo Qian, Shi-Chang Zhang, Fang Wang, et al.
Cell Biology International (2024) Vol. 48, Iss. 4, pp. 404-430
Open Access | Times Cited: 12
COVID-19 vaccines reduce the risk of SARS-CoV-2 reinfection and hospitalization: Meta-analysis
Maria Elena Flacco, Cecilia Acuti Martellucci, Valentina Baccolini, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 35
The unnaturalistic fallacy: COVID-19 vaccine mandates should not discriminate against natural immunity
Jonathan Pugh, Julian Savulescu, Rebecca C. H. Brown, et al.
Journal of Medical Ethics (2022) Vol. 48, Iss. 6, pp. 371-377
Open Access | Times Cited: 30
Real-world effectiveness and factors associated with effectiveness of inactivated SARS-CoV-2 vaccines: a systematic review and meta-regression analysis
Shiyao Xu, Jincheng Li, Hongyuan Wang, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 16
Seroconversion and dynamics of IgG anti-SARS-CoV-2 antibodies during the pandemic: A two-month observation cohort study on the population of Sleman in Indonesia
Jajah Fachiroh, Septi Kurnia Lestari, Dewi Kartikawati Paramita, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0316360-e0316360
Open Access
Post-COVID-19 functional status in socioeconomically vulnerable neighborhoods attended in primary health care in two Brazilian cities: a cross-sectional study
Danielle Souto de Medeiros, Gustavo Amorim, Fabiane Veloso Soares, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
Electrochemical Immunosensors Based on Zinc Oxide Nanorods for Detection of Antibodies Against SARS-CoV-2 Spike Protein in Convalescent and Vaccinated Individuals
Freddy A. Nunez, Ana Cristina Honorato de Castro, Vivian L. de Oliveira, et al.
ACS Biomaterials Science & Engineering (2022) Vol. 9, Iss. 1, pp. 458-473
Closed Access | Times Cited: 26
Comparative epidemic expansion of SARS-CoV-2 variants Delta and Omicron in the Brazilian State of Amazonas
Ighor Arantes, Gonzalo Bello, Valdinete Alves do Nascimento, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top